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ABSTRACT
Background: Laparoscopic paraesophageal hernia repair
(LPEHR) has been shown to be both safe and efficacious.
Compulsory operative steps include reduction of the
stomach from the mediastinum, resection of the medias-
tinal hernia sac, ensuring an appropriate intraabdominal
esophageal length, and crural closure. The use of mesh
materials in the repair of hiatal hernias remains controver-
sial. Synthetic mesh may reduce hernia recurrences, but
may increase postoperative dysphagia and result in
esophageal erosion. Human acellular dermal matrix
(HADM) may reduce the incidence of hernia recurrence
with reduced complications compared with synthetic
mesh.
Methods: A retrospective review of all cases of laparo-
scopic hiatal hernia repair using HADM from December
2008 through March 2010 at a single institution was per-
formed evaluating demographic information, BMI, opera-
tive times, length of stay, and complications.
Discussion: Forty-six LPEHRs with HADM were identi-
fied. The mean age of patients was 60.3 years (13.9);
BMI 30.3 (5.3); operative time 182 minutes (56); and
length of stay 2.6 days (1.9). Nine of 46 (19.6%) patients
experienced perioperative complications, including sub-
cutaneous emphysema without pneumothorax (n2), uri-
nary retention (n1), COPD exacerbation (n2), early
dysphagia resolving before discharge (n1), esophageal
perforation (n1), delayed gastric perforation occurring
30 days postoperatively associated with gas bloat syn-
drome (n1), and PEG site abscess (n1). There were 2
clinically recurrent hernias (4.3%). Radiographic recur-
rences occurred in 2 of 26 patients (7.7%). Six of 46 (13%)
patients reported persistent dysphagia.
Conclusion: LPEHR with HADM crural reinforcement is
an effective method of repairing symptomatic paraesoph-
ageal hernias with low perioperative morbidity. Recur-
rences occur infrequently with this technique. No mesh-
related complications were seen in this series.
Key Words: Paraesophageal hernia, Hiatal hernia, Lapa-
roscopy, Human acellular dermis.
INTRODUCTION
The surgical approach to repair of paraesophageal hernia
has shifted with the advent of minimally invasive technol-
ogies and techniques. The laparoscopic repair affords the
patients a quicker recovery, shorter hospital stay, and
quicker return to activity with less morbidity than with the
open approach.1 Compulsory operative steps include re-
duction of the stomach from the mediastinum, resection of
the mediastinal hernia sac, ensuring an appropriate intra-
abdominal esophageal length, and crural closure. How-
ever, studies have shown that primary suture-based re-
pairs of the crura have recurrence rates of 15% to 42%.2-5
Others have reported higher recurrence rates in those
undergoing laparoscopic repair relative to open repair.2
The utilization of mesh in both inguinal and ventral hernia
repairs has been shown to significantly improve recur-
rence rates.6 The application of mesh-based repairs to
paraesophageal hernia has also been shown to decrease
recurrence rates.7-10 The dynamic nature of the esophagus
relative to the esophageal hiatus raises concerns about
placement of a synthetic mesh to reinforce the crural
repair. Indeed, there exist reports of erosion of synthetic
mesh into the esophagus and dysphagia related to mesh-
associated fibrosis and scarring necessitating reopera-
tion.11-14
Given the concerns for mesh-related complications at the
hiatus and the lower recurrence rates associated with
mesh-based repairs, biologic meshes have been increas-
ingly used in laparoscopic paraesophageal hernia repair.
Biologic grafts are believed to provide an extracellular
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SCIENTIFIC PAPERcollagen matrix that is remodeled when utilized in hernia
repair to allow for a stronger repair. A multi-institutional
randomized controlled trial comparing porcine small in-
testinal submucosa buttressed hiatal hernia repair to pri-
mary repair showed a significant decrease in recurrence
without mesh-related complications.15 Human acellular
dermal matrix is an allogeneic graft also increasingly uti-
lized in abdominal wall repair as well as in paraesopha-
geal hernia repair. Small case series have demonstrated
recurrence rates with human acellular dermal matrix cru-
roplasty to range from 3.8% to 12%.16-18 In this study, the
outcomes following a consecutive series of laparoscopic
paraesophageal hernia repair with a human acellular der-
mal matrix are evaluated.
METHODS
Following Institutional Review Board approval, a retro-
spective review was conducted of all patients undergoing
laparoscopic repair of a paraesophageal hernia with hu-
man acellular dermis from December 2008 through March
2010. Only those hiatal hernias at least 5cm in craniocau-
dal length, as determined by preoperative endoscopy or
barium swallow, were included. The size of the hiatal
hernia was determined by measuring the distance from
the gastroesophageal junction to the diaphragm on pre-
operative imaging. Patient demographics, BMI, operative
times, length of stay, and complications were recorded.
Follow-up data were reviewed to identify postoperative
complaints, specifically the presence or absence of dys-
phagia to solids. Postoperative barium esophagrams and
esophagogastroduodenoscopies were reviewed to iden-
tify recurrences and/or mesh complications.
A standardized technique was utilized for all laparoscopic
paraesophageal hernia repairs. A minimum of 2.5cm of
intraabdominal esophageal length is obtained with exten-
sive mediastinal dissection (Figure 1). Intraabdominal
esophageal length is measured intraoperatively from the
diaphragm to the gastroesophageal junction while the
stomach is held tension-free. Complete mobilization of
the fundus and cardia of the stomach is performed with
preservation of the peritoneal covering of the crura. A 54
French bougie is passed per os and directed along the
lesser curvature of the stomach to size the cruroplasty.
The diaphragmatic crura are closed using interrupted per-
manent sutures (Figure 2) to allow for approximation of
the crural fibers, allowing for a 5-mm instrument to be
placed between the esophagus and crural closure while
the bougie is in position, thus ensuring no extrinsic com-
pression from the crural closure is placed on the esoph-
agus. Hernias 5cm in size noted on preoperative barium
study15 or endoscopy, or the presence of attenuated crura
were criteria for the use of human acellular dermal graft.
A 5cm x 8cm graft of human acellular dermis is fashioned
into a “U” shape and is placed as an onlay patch over the
cruroplasty posterior to the esophagus with the tails of the
“U” placed to either side of the esophagus. Care is taken
to ensure the mesh is not impinging on the esophagus. An
Endoscopic Universal 65 Hernia Stapler (Covidien, Mans-
field, MA) is used to secure the mesh to the diaphragm
(Figures 3 and 4). A 360-degree fundoplication is then
fashioned over a 54 French bougie. Completion endos-
copy is performed to visualize the fundoplication and
ensure no esophageal or gastric injury. Percutaneous en-
doscopic gastrostomy tubes are placed selectively in pa-
tients with large paraesophageal hernias in which more
Figure 1. Hiatal defect.
Figure 2. Cruroplasty.
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defect with the appearance of a dilated or atonic stomach
after the completion of the dissection.
RESULTS
Forty-six patients underwent laparoscopic paraesopha-
geal hernia repair with human acellular dermis. There
were 11 male and 35 female patients (Table 1). Five
patients underwent surgery for recurrent hiatal hernias,
one of whom had undergone prior repair with mesh. The
average age was 60.3 years (13.9), and the average BMI
was 30.3 (5.3). Mean operative time was 182 minutes
(56), and mean postoperative length of stay was 2.6
days (range, 1 to 8). Forty-three patients had AlloMax
(Bard Davol, Warwick, RI), while 2 patients had Flex HD
(Ethicon, Somerville, NJ), and 1 patient had AlloDerm
(Lifecell, Branchburg, NJ). Forty-three patients underwent
primary crural closure with placement of the graft as
reinforcement. Three patients had attenuated crura that
were unable to be reapproximated and underwent hernia
closure with a bridging graft of human acellular dermis.
Two of these patients had a complete intrathoracic stom-
ach, and the third patient presented with a 50% intratho-
racic stomach, all with significant separation of the crura.
Primary crural closure was unsuccessful following crural
dissection in these cases, and the decision was made to
perform a bridging repair with a graft. Two patients re-
quired the addition of a Collis gastroplasty to achieve
adequate intraabdominal esophageal length. Nineteen pa-
tients underwent concomitant placement of a gastrostomy
tube at the time of surgery. All gastrostomy tubes were
removed by the sixth postoperative week. Mean fol-
low-up was 3.6 months with a range of 1 to 14 months.
Perioperative complications occurred in 9 patients (19.5%,
Table 1). Two patients developed subcutaneous emphy-
sema without pneumothorax, 2 patients had an exacerba-
tion of their preoperative chronic obstructive pulmonary
disease requiring medical management, and 1 patient de-
veloped urinary retention. One patient experienced early
postoperative dysphagia requiring a prolonged hospital
stay. This patient’s dysphagia resolved without long-term
complication. An intraoperative esophageal perforation
Figure 3. Human acellular dermis onlay.
Figure 4. Human acellular dermis onlay.
Table 1.
Patient Demographics and Results
Age 60.3  13.9 yr
BMI 30.3  5.3
Operative Time 182  56 min
Length of stay 2.6 days (range, 1 to
8)
Recurrences
Clinical 2/46 (4.3%)
Radiographic 2/26 (7.7%)
Dysphagia 6/46 (13%)
Early Complications 9/46 (19.6%)
Intraop esophageal
perforation
1
Delayed gastric perforation 1
Subcutaneous emphysema 2
Urinary retention 1
COPD exacerbation 2
PEG site abscess 1
Early dysphagia 1
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was repaired intraoperatively with no postoperative se-
quelae. One patient complained of gas bloat in the post-
operative setting and developed a gastric perforation of
the anterior body of the stomach 30 days following hiatal
hernia repair. This patient required operative intervention
with primary gastric closure. One patient developed an
abscess at the site of a gastrostomy tube, which was
treated with local wound care. Postoperative barium
esophagrams were obtained in 26 patients. Radiographic
recurrence of the hiatal hernia occurred in 2 patients. One
of these patients subsequently underwent laparoscopic
revision without clinical or radiographic recurrence. The
second recurrence was managed nonoperatively. Dyspha-
gia for solids occurred in 6 patients (13%). There was no
dysphagia for liquids. No mesh erosions or mesh-related
complications were seen.
DISCUSSION
The successful repair of large paraesophageal hernias
continues to be a challenge. Recurrence rates have been
reported to range up to 42% with primary suture-based
repairs.2-4 The utilization of mesh products at the esoph-
ageal hiatus remains controversial. Although some au-
thors have advocated routine utilization of mesh rein-
forcement of the esophageal hiatus,15 others have taken a
selective approach. A recent report of 662 hiatal hernia
repairs demonstrated a radiographic recurrence rate of
15.7%, and a clinical recurrence rate necessitating a reop-
eration rate of 3.2% utilizing a selective approach to rein-
forcing the crura with mesh.5 As with abdominal wall
hernia repair there is a plethora of products available to
use. A recent survey of 264 SAGES members showed that
biomaterials were utilized 28.3% of the time, PTFE 25.3%,
and polypropylene 21.1%.19 To date, there has been one
multi-center randomized prospective trial comparing su-
ture-based repair of paraesophageal hernia to repair rein-
forced with a biologic mesh, porcine small intestinal sub-
mucosa. This study has shown a significant decrease in
recurrence rates without evidence of mesh complica-
tions.15
Wisbach and colleagues18 reported their initial experience
using human acellular dermal matrix in laparoscopic type
III paraesophageal hernia repair in 11 patients with 1
recurrence on barium esophagram and 1 case of dyspha-
gia. Lee and colleagues17 reported on a series of 17 pa-
tients undergoing laparoscopic hiatal hernia repair using
human acellular dermal matrix. Two small recurrent her-
nias were seen on follow-up barium studies and 1 patient
reported mild dysphagia. Ringley et al20 compared 22
patients undergoing cruroplasty reinforced with human
acellular dermis to 22 historical controls undergoing pri-
mary suture-based cruroplasty. The authors report a 9%
recurrence with primary sutured cruroplasty and 0% re-
currence with the human acellular dermis onlay rein-
forced cruroplasty. Our current series adds to the experi-
ence with human acellular dermis in paraesophageal
hernia repair. Of the 46 patients undergoing repair, 43 had
AlloMax (CR Bard, Warwick, RI) while 2 had Flex HD
(Musculoskeletal Transplant Foundation, Edison, NJ), and
1 had AlloDerm (LifeCell, Branchburg, NJ). Five of the
repairs were performed for recurrent hernias. Four of
these repairs had been performed previously at other
facilities without the use of mesh. One patient had previ-
ously undergone repair with a biologic mesh. Barium
esophagrams were available in 26 patients between 6
weeks and 1 year postoperatively. Our series demon-
strated 2 symptomatic recurrences noted in 46 patients.
Both of these patients underwent a barium esophagram as
part of a clinical evaluation of their recurrent symptoms.
The first patient had recurrent reflux symptoms with a
barium esophagram at 4.5 months after surgery, showing
a 2-cm recurrent hernia with associated reflux. The patient
underwent endoscopy, which demonstrated esophagitis.
He was initially treated with proton pump inhibitors but
ultimately elected to proceed with revisional surgery. At
the time of revisional surgery, his crural closure had sep-
arated, resulting in a posterior recurrence of the hiatal
hernia. The human acellular dermal graft remained visible
only in the areas overlying the crural fibers. There was no
evidence of the graft in the area of the hernia recurrence.
The crural defect was repaired with primary crural closure
and placement of a human acellular dermal graft. He
remains symptom free 6 months following his revisional
surgery. The second patient with a recurrence had initially
undergone repair of a recurrent hiatal hernia. She had
dysphagia preoperatively and continued to complain of
mild postoperative dysphagia. A small recurrent hernia
was noted on barium swallow 4 months postoperatively,
and EGD revealed a 2-cm sliding hiatal hernia. The patient
underwent a repeat barium esophagram 1 year following
her surgery, which demonstrated a stable recurrent hiatal
hernia.
This series describes the utilization of a hernia stapler to
secure the human acellular dermis to the diaphragm. With
an open staple height of 4.0mm, care must be taken to
avoid placement into tissues directly overlying vascular
structures. However, the staple design allows for the tis-
sue to be pulled into the stapler rather than pushing the
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tential for injury. Although the strength of attachment of
the tacks is not measured, the circumferential staples re-
sult in secure fixation of the graft. Additionally, circumfer-
ential placement of staples also allows for the graft to be
placed smoothly opposed to the diaphragm to allow for
maximal vascular ingrowth. In our study, no complica-
tions occurred as a result of the utilization of a stapler for
placement of the mesh.
Laparoscopic paraesophageal hernia repair with human
acellular dermis has low recurrences rates similar to that in
other series (Table 2). Mesh-related complications, such
as erosions and stricture, have been reported with syn-
thetic mesh products at the hiatus.11-14,21,22 Stadlhuber et
al22 compiled a 28 case series of patients with mesh
complications after having undergone hiatal hernia repair
with mesh. Seven of the 28 patients’ complications in-
volved biologic mesh products and include 1 esophageal
erosion, 4 cases of esophageal stenosis, and 2 patients
with dense fibrosis. In our series, there was no mesh
erosion. This series reports a 13% incidence of postoper-
ative dysphagia. Six patients report persistent dysphagia
to solids. Two of these patients experienced dysphagia
prior to their operation. Preoperative dysphagia has been
shown to correlate with the incidence of postoperative
dysphagia.5 In only 1 of the 6 patients with postoperative
dysphagia was an anatomic narrowing appreciated on
barium imaging. This was the patient in which an intra-
operative esophageal perforation was identified and re-
paired primarily. This patient did not have any immediate
postoperative sequelae from the iatrogenic bougie injury,
but has required endoscopic esophageal dilation with
improvement of her symptoms. Although biologic mesh
may play a role in reducing the risk of hiatal hernia
recurrence, there may be a resultant increased risk of
dysphagia associated with its use at the esophageal hiatus.
In the previously mentioned prospective trial, patients
with mesh at the hiatus had a higher dysphagia symptom
severity score 6 months following their operation than
those repaired without mesh.15
The routine use of mesh as a reinforcement to the crural
closure at the time of hiatal hernia repair remains a topic
of debate. In a large retrospective study of hiatal hernia
repairs, the selective use of reinforcing mesh in as few as
12% of patients resulted in a clinical recurrence rate of
3%.5 In the aforementioned study, the utilization of mesh
was associated with an increased odds ratio for reopera-
tion for recurrence, suggesting that the ideal approach is
unknown. On the contrary, a prospective randomized trial
utilizing small intestinal submucosal mesh as a reinforce-
ment demonstrated a reduction in radiographic recur-
rences from 24% without mesh to 9% with mesh at 6
months follow-up, thus suggesting a benefit to routine
mesh reinforcement. But, the long-term durability of the
mesh repair remains an area of uncertainty. Laparoscopic
hiatal hernia repair is a difficult operation and its success-
ful accomplishment requires meticulous dissection to
achieve adequate esophageal mobilization and crural dis-
section without vagal or visceral injuries. Appropriate uti-
lization of esophageal lengthening procedures in also
paramount to long-term success.
The routine utilization of mesh reinforcement of the hiatus
attempts to minimize recurrences by offloading tension on
the crural closure. Routine use of biologic mesh is safe
with few reported mesh complications, although side ef-
fects and complications are possible. Prospective studies
that delineate objective criteria for mesh utilization follow-
ing hiatal hernia repair are necessary to adopt a selective
approach.
In our study, 19 patients received gastrostomy tubes, re-
sulting in 1 tube-related complication. Of the 2 recurrent
hernias that occurred, one patient was treated with a
gastrostomy tube and one patient was treated without a
gastrostomy tube. The authors have since abandoned the
utilization of gastrostomy tubes during hiatal hernia re-
pair, because we do not feel such tubes offer any signif-
icant advantage.
CONCLUSION
Laparoscopic paraesophageal hernia repair with human
acellular dermis reinforced cruroplasty is feasible and
safe. Fixation of the graft may be safely performed with a
hernia stapler. The use of human acellular dermis as a
crural reinforcement results in a low hernia recurrence
rate. However, there is likely a tradeoff between recur-
rence rate and dysphagia. Long-term follow-up is needed
to better understand the implications of placing a human
acellular dermal graft at the esophageal hiatus during
paraesophageal hernia repairs.
Table 2.
Series Utilizing Human Acellular Dermal Matrix
Series Recurrence Dysphagia
Wisbach
17 1/11 (9.1%) 1/11 (9.1%)
Lee E
16 2/17 (11.8%) 1/17 (5.9%)
Lee Y
15 2/52 (3.8%) Not reported
Current series 2/46 (4.3%) 6/46 (13.0%)
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